|
John G. Cooper is responsible for all of the company’s financial and investor relations matters. Mr. Cooper has extensive experience in managing the needs of emerging growth companies including public and private equity financings, investor relations, strategic alliances, mergers and acquisitions, strategic and financial planning, and development of financial management and accounting systems for international operations. Previously to Discovery Labs, Mr. Cooper held several senior financial positions including Chief Financial Officer at Mobility Technologies, Inc., a venture capital backed wireless technology company, Chief Financial Officer at Taratec Development Corporation, a venture capital backed provider of information technology solutions to the life sciences industry, Senior Vice President and Chief Financial Officer of Chrysalis International Corporation, a public company (ultimately acquired by MDS Pharmaceuticals, Inc.) providing drug development services to the life sciences industry, and Senior Vice President and Chief Financial Officer of DNX Corporation, a public biotechnology company, where Mr. Cooper managed its initial public offering in 1991. Prior to DNX, Mr. Cooper was Director, Finance and Controller of ENI Diagnostics (a public life sciences company acquired by Pharmacia in 1989). Mr. Cooper is a certified public accountant and received his B.S. in Commerce from Rider University. | 